A Study of Anlotinib in Patients With Hepatocellular Carcinoma
Clinical trial NCT02809534 · UNKNOWN
Trial details
- NCT number
- NCT02809534
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.